©The Author(s) 2022.
World J Gastrointest Endosc. Nov 16, 2022; 14(11): 657-666
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.657
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.657
Table 1 Risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in the European Society of Gastrointestinal Endoscopy and American Society for Gastrointestinal Endoscopy guidelines
| ESGE guideline | ASGE guideline |
| Patient-related definitive risk factors | Patient-related risk factors |
| Suspected sphincter of Oddi dysfunction | Suspected sphincter of Oddi dysfunction |
| Female sex | Female sex |
| Previous pancreatitis | Previous recurrent pancreatitis |
| Previous post-ERCP pancreatitis | Previous post-ERCP pancreatitis |
| Procedure-related definitive risk factors | Younger age |
| Difficult cannulation | Absence of chronic pancreatitis |
| More than one pancreatic guidewire passage | Normal serum bilirubin |
| Pancreatic injection | Procedure-related risk factors |
| Patient-related likely risk factors | Difficult cannulation (> 10 min) |
| Younger age | Repeated pancreatic guidewire cannulation |
| Nondilated extrahepatic bile duct | Pancreatic injection |
| Absence of chronic pancreatitis | Endoscopic papillary large-balloon dilation of a native papilla |
| Normal serum bilirubin | |
| End-stage renal failure | |
| Procedure-related likely risk factors | |
| Precut sphincterotomy | |
| Pancreatic sphincterotomy | |
| Papillary balloon dilation | |
| Unsuccessful clearance of bile duct stones | |
| Intraductal ultrasound |
- Citation: Saito H, Fujimoto A, Oomoto K, Kadowaki Y, Tada S. Current approaches and questions yet to be resolved for the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. World J Gastrointest Endosc 2022; 14(11): 657-666
- URL: https://www.wjgnet.com/1948-5190/full/v14/i11/657.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i11.657